Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Bytes Technology non-exec linked to £11k share purchase

(Sharecast News) - Bytes Technology topped a short list of director buys on Friday afternoon, after a non-executive director was linked to a purchase worth over £11k. The FTSE 250 company said 3,000 shares were purchased in a single transaction on the London Stock Exchange on Wednesday.

It said the purchaser was "closely associated to" its director David Maw, without naming the entity involved.

The buyer paid 371.17p for each share, valuing the investment at a total of £11,135.10.

Following the transaction, Bytes said Maw had a beneficial holding of 17,865 of its shares.

At 1430 BST, shares in Bytes Technology Group were down 1.6% at 368.4p.

There were no director-linked share sales to note on Friday afternoon.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Bytes Technology Group (BYIT) Director name: Maw,David Amount purchased: 3,000 @ 371.17p Value: £11,135.10

Pharos Energy (PHAR) Director name: Brown,Jann M Amount purchased: 25,231 @ 25.95p Value: £6,547.32

Pharos Energy (PHAR) Director name: Rivett,Sue Amount purchased: 3,758 @ 25.95p Value: £975.18

Arix Bioscience (ARIX) Director name: Moncreiffe,Peregrine D E M Amount purchased: 50,000 @ 1.04p Value: £520.00

Arix Bioscience (ARIX) Director name: Moncreiffe,Peregrine D E M Amount purchased: 25,000 @ 1.04p Value: £260.00

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.